90795404
Jun 25, 2021
Pharmaceutical preparations for the treatment of neurological diseases and neurodegenerative diseases; pharmaceutical preparations, namely, preparations for use in the treatment of Amyotrophic Lateral Sclerosis (ALS); pharmaceutical preparations, namely, B cell therapies for the treatment of neuroinflammation and immune dysregulation; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for the treatment of autoimmune diseases and traumatic brain injuries
PharmaceuticalsPharmaceutical research and development; Research and development services in the field of cell therapy
Computer and Scientific